DAFNA Capital Management LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$5,023,150
+32.7%
550,784
+53.9%
1.56%
+50.9%
Q2 2023$3,785,355
+181.9%
357,784
+225.9%
1.04%
+156.8%
Q1 2023$1,342,658
-25.3%
109,784
-24.2%
0.40%
-20.4%
Q4 2022$1,796,769
-36.2%
144,784
-29.8%
0.51%
-33.2%
Q3 2022$2,818,000
+30.5%
206,329
+75.1%
0.76%
+28.7%
Q2 2022$2,160,000
+18.6%
117,829
+4.0%
0.59%
+24.0%
Q1 2022$1,822,000
+17.4%
113,329
+2.3%
0.48%
+21.8%
Q4 2021$1,552,000
-17.8%
110,829
+9.9%
0.39%
-22.2%
Q3 2021$1,889,000
+8.4%
100,829
+20.7%
0.50%
+37.6%
Q2 2021$1,742,000
+19.0%
83,529
+61.3%
0.36%
+4.9%
Q1 2021$1,464,000
+398.0%
51,800
+475.6%
0.35%
+298.9%
Q4 2020$294,000
-75.4%
9,000
-76.9%
0.09%
-77.6%
Q3 2020$1,196,000
-75.1%
39,019
-86.7%
0.39%
-71.9%
Q2 2020$4,796,000
+56.7%
294,260
-4.3%
1.38%
+8.4%
Q1 2020$3,060,000
+28.3%
307,541
+77.3%
1.28%
+55.9%
Q4 2019$2,385,000
+51.7%
173,475
+67.4%
0.82%
+38.6%
Q3 2019$1,572,000
+69.0%
103,658
+119.4%
0.59%
+68.9%
Q2 2019$930,000
+53.5%
47,242
+29.2%
0.35%
+34.1%
Q1 2019$606,000
-71.0%
36,558
-75.4%
0.26%
-74.9%
Q4 2018$2,087,000
-50.4%
148,617
-38.2%
1.04%
-39.9%
Q3 2018$4,209,000
-3.4%
240,500
+0.4%
1.73%
-15.3%
Q2 2018$4,359,000
+83.1%
239,500
+88.6%
2.04%
+76.3%
Q1 2018$2,381,000
+32.7%
127,000
+8.3%
1.16%
+19.9%
Q4 2017$1,794,000
+13.3%
117,281
+10.8%
0.97%
-1.7%
Q3 2017$1,583,000105,8590.98%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,849,947$16,871,5179.37%
Prosight Management, LP 1,932,456$17,623,9995.58%
ACUTA CAPITAL PARTNERS, LLC 702,093$6,403,0884.29%
ALETHEA CAPITAL MANAGEMENT, LLC 350,445$3,196,0583.93%
SUVRETTA CAPITAL MANAGEMENT, LLC 7,335,845$66,902,9063.62%
Affinity Asset Advisors, LLC 856,535$7,811,5992.20%
TCG Crossover Management, LLC 1,423,642$12,983,6151.91%
EcoR1 Capital, LLC 5,806,871$52,958,6641.79%
BVF INC/IL 6,730,983$61,386,5651.66%
DAFNA Capital Management LLC 550,784$5,023,1501.56%
View complete list of KURA ONCOLOGY INC shareholders